文献速递慢性肾脏病肾小球疾病

非酒精性脂肪性肝炎小鼠模型中的慢性肾脏病

Chronic kidney disease in a murine model of non-alcoholic steatohepatitis (NASH).
PubMed 文献 · Kidney Int · 2023-12-28

该研究在验证充分的小鼠NASH模型中评估肾脏功能、组织学、转录组和脂质组,发现NASH小鼠逐步出现足细胞足突融合、蛋白尿、肾小球硬化、肾小管损伤、脂质蓄积和间质纤维化;通过原位肝移植证实NASH与CKD的因果关系,并在人NASH合并CKD中观察到相似肾脏组织学改变。

要点

  • NASH小鼠模型可逐步诱导CKD样肾脏损伤。
  • 原位肝移植可减轻NASH相关蛋白尿、肾功能异常和纤维化。
  • 人NASH合并CKD可见相似肾脏组织学改变。

核心结论

  • NASH在小鼠模型中可因果性促进CKD发生,并揭示线粒体功能障碍、脂质代谢和胰岛素信号通路等潜在机制。

研究设计与样本

  • 研究在验证充分的小鼠NASH模型中表征肾脏功能、组织学、转录组和脂质组,并通过原位肝移植与对照假手术比较评估因果关系。

主要发现

  • NASH小鼠逐步出现显著的足细胞足突融合、蛋白尿、肾小球硬化、肾小管上皮细胞损伤、脂质蓄积和间质纤维化。
  • 肾脏纤维化进展与组织学NASH活动度评分严重程度平行。
  • 原位肝移植相比对照假手术小鼠减轻蛋白尿、肾功能异常和纤维化。
  • 小鼠肾皮质转录组分析显示差异表达基因高度富集于线粒体功能障碍、脂质代谢过程和胰岛素信号通路。
  • 肾皮质脂质组分析显示磷脂和鞘脂是变化最显著的脂质种类。

临床怎么用

  • 提示NASH患者应关注肾脏损伤筛查与监测,NASH可能为CKD独立风险因素。

局限性

  • 研究基于小鼠NASH模型,人类证据为组织学相似性观察,尚需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical studies suggest that non-alcoholic steatohepatitis (NASH) is an independent risk factor for chronic kidney disease (CKD), but causality and mechanisms linking these two major diseases are lacking. To assess whether NASH can induce CKD, we have characterized kidney function, histological features, transcriptomic and lipidomic profiles in a well-validated murine NASH model. Mice with NASH progressively developed significant podocyte foot process effacement, proteinuria, glomerulosclerosis, tubular epithelial cell injury, lipid accumulation, and interstitial fibrosis. The progression of kidney fibrosis paralleled the severity of the histologic NASH-activity score. Significantly, we confirmed the causal link between NASH and CKD by orthotopic liver transplantation, which attenuated proteinuria, kidney dysfunction, and fibrosis compared with control sham operated mice. Transcriptomic analysis of mouse kidney cortices revealed differentially expressed genes that were highly enriched in mitochondrial dysfunction, lipid metabolic process, and insulin signaling pathways in NASH-induced CKD. Lipidomic analysis of kidney cortices further revealed that phospholipids and sphingolipids were the most significantly changed lipid species. Notably, we found similar kidney histological changes in human NASH and CKD. Thus, our results confirm a causative role of NASH in the development of CKD, reveal potential pathophysiologic mechanisms of NASH-induced kidney injury, and established a valuable model to study the pathogenesis of NASH-associated CKD. This is an important feature of fatty liver disease that has been largely overlooked but has clinical and prognostic importance.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Li X, Bhattacharya D, Yuan Y, et al. Chronic kidney disease in a murine model of non-alcoholic steatohepatitis (NASH). Kidney Int. 2023. PMID: 38159678. doi:10.1016/j.kint.2023.12.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。